19: Sikiric P, Gojkovic S, Krezic I, Smoday IM, Kalogjera L, Zizek H, Oroz K, Vranes H, Vukovic V, Labidi M, Strbe S, Baketic Oreskovic L, Sever M, Tepes M, Knezevic M, Barisic I, Blagaic V, Vlainic J, Dobric I, Staresinic M, Skrtic A, Jurjevic I, Boban Blagaic A, Seiwerth S
The future of GLP-1 and gut health Research into the impact of GLP-1 drugs on the gut is growing all the time
Pathogenesis Protrusion of cytoplasm into an invagination of the hepatocyte nuclear membrane without the actual protrusion necessarily being present in the plane of section
The typical pattern is to taper retatrutide down, keep cagrilintide at maintenance (1.7-2.4 mg/week), then resume retatrutide after a 4-8 week washout
Gut microbe-derived metabolite trimethylamine n-oxide induces cardiac hypertrophy and fibrosis